Transparency and reporting characteristics of COVID-19 randomized controlled trials.

Kapp, Philipp; Esmail, Laura; Ghosn, Lina; Ravaud, Philippe; Boutron, Isabelle

Kapp, Philipp; Esmail, Laura; Ghosn, Lina; Ravaud, Philippe; Boutron, Isabelle.

Afiliação

Kapp P; Université Paris Cité, Inserm, INRAE, Centre of Research in Epidemiology and Statistics (CRESS), F-75004, Paris, France.
Esmail L; Centre d'Épidémiologie Clinique, AP-HP, Hôpital Hôtel-Dieu, F-75004, Paris, France.
Ghosn L; Cochrane France, F-75004, Paris, France.
Ravaud P; Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, D-79110, Freiburg, Germany.
Boutron I; Université Paris Cité, Inserm, INRAE, Centre of Research in Epidemiology and Statistics (CRESS), F-75004, Paris, France.

BMC Med ; 20(1): 363, 2022 09 26.

Article em En | MEDLINE | ID: mdl-36154932

Assuntos

COVID-19; Humanos; Disseminação de Informação; Revisão por Pares; Ensaios Clínicos Controlados Aleatórios como Assunto; Relatório de Pesquisa

Palavras-chave

CONSORT; COVID-19; Peer review; Completeness of reporting; Quality of reporting; Randomized controlled trial; Selection bias; Selective outcome reporting; Transparency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google